01 Oct Probiotic therapy alleviates SIBO but has no effect on liver disease
Posted at 14:25h
in Small Intestinal Bacterial Overgrowth
This research focused on the benefits of using probiotic therapy for patients with chronic liver disease, small intestinal bacterial overgrowth (SIBO) and intestinal permeability problems. The study enrolled 53 patients who consumed for 4 weeks a cocktail of 6 bacterial species. The result was that SIBO was resolved in many of the patients but intestinal permeability was not. This led the researchers to conclude that in liver disease patients’ probiotics are effective treatment for SIBO.
Ref: Eur J Gastroenterol Hepatol 2014 Sept 19